BiotechTube
NeuraMedica

NeuraMedica

San Diego, United States· Est.
neuramedica.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $4.8M

Overview

NeuraMedica is a commercial-stage medical device company that has developed and received FDA 510(k) clearance for the DuraFuse Dural Clip system. The device addresses a critical need in spinal surgery by offering a faster, simpler method for dural closure that reduces cerebrospinal fluid (CSF) leakage and operating room time compared to suturing. The company has been funded primarily through non-dilutive grants and a small amount of private investment, totaling over $3.5 million since its inception. Its leadership combines clinical insight from a neurosurgeon co-founder with engineering and business expertise.

NeurosurgerySpinal Disorders

Technology Platform

Bioabsorbable polymer clip and applier system for non-penetrating soft tissue closure, designed to be rapid, secure, and imaging-compatible.

Funding History

1
Total raised:$4.8M
Seed$4.8M

Opportunities

DuraFuse addresses a clear unmet need for faster, more reliable dural closure in the large and growing spinal surgery market.
Its non-penetrating, bioabsorbable design offers distinct clinical advantages over sutures and sealants, with potential to reduce complications and lower overall procedural costs.
The technology platform could be expanded to other surgical applications requiring secure, leak-proof tissue approximation.

Risk Factors

Commercialization risk is high, as a small company must establish sales traction against entrenched surgical practices and larger competitors.
The business is reliant on a single product, creating significant concentration risk.
Future growth will likely require additional capital, which may be dilutive.

Competitive Landscape

Competition includes traditional sutures (the standard of care), dural sealants and patches (e.g., from Baxter, Integra LifeSciences), and other closure devices. DuraFuse's key differentiators are its non-penetrating mechanism, which eliminates suture-hole leaks, and its bioabsorbable, imaging-compatible polymer construction. It must compete on cost, ease of use, and clinical outcomes to gain market share.

More companies in Drug Delivery & Formulation →More companies in United States →